Skip to content

Distolingual Infiltration Verses Conventional Nerve Block in Mandibular Third Molar Extraction

Comparison of Efficacy of Distolingual Infiltration in Conjugation With Conventional Inferior Alveolar Nerve Block to Conventional Inferior Alveolar Nerve Block Alone for Extraction of Mandibular Third Molar

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07296926
Enrollment
120
Registered
2025-12-22
Start date
2024-08-15
Completion date
2026-04-15
Last updated
2026-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain (Visceral, Somatic, or Neuropathic)

Brief summary

This randomized controlled trial will compare the effectiveness of adding distolingual infiltration to conventional inferior alveolar and buccal nerve blocks for mandibular third molar extraction. A total of 120 patients will be allocated into two groups. Pain during flap elevation and bone guttering will be assessed using the Visual Analogue Scale.

Detailed description

Mandibular third molar extraction is a common oral and maxillofacial surgery procedure that requires profound local anesthesia. Despite conventional inferior alveolar, lingual and buccal nerve blocks, the distolingual gingiva may remain non-anesthetized due to accessory innervation via the mylohyoid and other nerves. Distolingual infiltration may improve anesthesia in this area. This randomized controlled trial will enroll 120 patients requiring mandibular third molar extraction. Participants will be randomized into two groups: conventional inferior alveolar and buccal nerve block (Group A) and the same technique with additional distolingual infiltration (Group B). Pain during mucoperiosteal flap elevation and bone guttering will be recorded on a 0-10 Visual Analogue Scale. The primary objective is to determine whether distolingual infiltration improves pain control compared to the conventional technique.

Interventions

PROCEDUREConventional Inferior Alveolar and Buccal Nerve Block

Standard inferior alveolar and long buccal nerve block for mandibular third molar extraction.

PROCEDUREDistolingual Infiltration plus Conventional Nerve Block

Distolingual infiltration (0.2 ml) administered in addition to conventional inferior alveolar during mandibular third molar extraction.

Sponsors

Watim Medical & Dental College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy individuals * Male and female * Age 18-45 years * Mandibular third molar impaction - all positions * Mandibular third molar impaction - all classes

Exclusion criteria

* ASA status III and above * Patients requiring multiple extractions in the same appointment * Allergy to lignocaine * Patients in whom adrenaline is contraindicated * Medically compromised individuals e.g. poorly controlled diabetes, hypertension

Design outcomes

Primary

MeasureTime frameDescription
Pain during mucoperiosteal flap elevationDuring mucoperiosteal flap elevation on the day of surgeryPain intensity experienced during flap elevation will be assessed using the Visual Analogue Scale (VAS). This is a 0-10 point numerical scale where participants indicate the pain level experienced at the time of flap elevation. Measurement Tool: Visual Analogue Scale (VAS) Scale: * Minimum score: 0 (no pain) * Maximum score: 10 (worst possible pain) * Directionality: Higher scores indicate worse pain
Pain During Bone GutteringDuring bone guttering on the day of surgery.Pain intensity during bone guttering will be recorded using the Visual Analogue Scale (VAS). Measurement Tool: Visual Analogue Scale (VAS) Scale: * Minimum: 0 (no pain) * Maximum: 10 (worst pain) * Higher scores = worse pain

Countries

Pakistan

Contacts

Primary Contactdr aimen zafar Aimen zafar, bds
aimenali216@gmail.com+923361056720

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026